SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4/A - Statement of changes in beneficial ownership of securities: [Amend]
SEC Accession No. 0001437749-22-002263
Filing Date
2022-02-02
Accepted
2022-02-02 20:18:58
Documents
1
Period of Report
2021-11-01

Document Format Files

Seq Description Document Type Size
1 FORM 4/A rdgdoc.html 4/A  
1 FORM 4/A rdgdoc.xml 4/A 7740
  Complete submission text file 0001437749-22-002263.txt   9468
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Issuer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O DIFFUSION PHARMACEUTICALS INC. 1317 CARLTON AVENUE, SUITE 200 CHARLOTTESVILLE VA 22902
Business Address
Cobuzzi Robert Joseph Jr. (Reporting) CIK: 0001799838 (see all company filings)

Type: 4/A | Act: 34 | File No.: 001-37942 | Film No.: 22586004